Moving Beyond Human Error in Biopharma Operations and CAPA Programs

It was a pleasure to collaborate as this topic applies to any function supporting pharma operations – QA, maintenance, QC and tech services. Every function designs its systems, procedures and workflows to get work done, and the interface between systems is where the risk of failure is highest. When events occur, we often drill down for specific reasons -- operator training, documentation clarity, variability in work conditions at the time of execution, etc. But we often fail to see the hand-offs between people in carrying out a task; the setup by one person and implementation by another, cleaning by one person and sampling by another, etc. We need to shift our focus to sometimes drill down more deeply and other times to step back and look at the factors that created the context which permitted an event to occur.
The roundtable panelists mentioned the value of operational learning, especially proactive learning through pre-and post-job briefs, and the application of learning teams. Creating opportunities for feedback from operations is the fuel for operational improvement. This requires building in the time for operational learning. For example, a production run in pharma operations is not complete until the documentation/batch record is finished and available for QA review and disposition. A new paradigm to consider is that batch setup and teardown is not complete unless it includes a pre -and post-job brief.
We hope these articles will help you see more clearly what actions you can take in your operations to ensure there is ongoing operational learning. We welcome your feedback and examples of how proactive operational learning is embedded in your operations.
How NSF Can Help You

What’s New with NSF

iNADO Partners with NSF to Support Members and Athletes
May 27, 2026iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve
NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation
May 20, 2026NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.